Medisca to pay $21.75m to resolve inflated pricing charges
Medisca has agreed to pay $21.75m to settle the allegations of false and inflated Average Wholesale Prices (AWPs) for two ingredients, resveratrol and mometasone furoate, used by pharmacies in compound...
The impact of misinformation and disinformation in the food, beverage, and nutraceutical ingredients industry
Inflation in the food, beverage, and nutraceutical ingredients industry: strategies and insights
How extreme weather events affect the food, beverage, and nutraceutical ingredients industry?
Economic downturn: challenges and strategies for the food, beverage, and nutraceutical ingredients industry